On the Board

Some 40 percent of the largest pharmaceutical companies have at least one board member on their board of directors who is also in a leadership position at an academic medical center, researchers led by Walid Gellad from the VA Pittsburgh Healthcare System and his colleagues report in the Journal of the American Medical Association this week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In PLOS this week: genomic analysis of Malaysian tuberculosis strain, database of bat genomes, and more.

An editorial appearing at The Scientist bemoans the high numbers of mitochondrial genome papers and suggests a different path for mitochondrial genome research.

Researchers and drug developers are excited about the potential of CRISPR-Cas9-based therapeutics, the Wall Street Journal reports.

US lawmakers want to develop a new incarnation of the National Children's Study, ScienceInsider reports.